A randomized, 3-period, multiple-dose, multicenter study to evaluate the safety, tolerability, and plasma concentration profile of montelukast administered once daily as oral granules in children aged 3 to 6 months

Trial Profile

A randomized, 3-period, multiple-dose, multicenter study to evaluate the safety, tolerability, and plasma concentration profile of montelukast administered once daily as oral granules in children aged 3 to 6 months

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Asthma; Bronchiolitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 12 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top